DEA Judge’s Cannabis Research Ruling Triggers Major Constitutional Challenge for MMJ BioPharma
A recent administrative ruling by a Drug Enforcement Administration (DEA) judge against a company seeking to develop pharmaceutical-grade cannabinoid therapies has ignited a significant legal challenge, potentially forcing a constitutional showdown in federal court. Chief Administrative Law Judge John J. Mulrooney II of the DEA issued a ruling described by the affected company, MMJ BioPharma…

